The increase was driven by similar jumps in the company’s reconstructive, MedSurg, neurotechnology and spine business lines. The company also reported a net earnings increase of 14 percent to $350 million.
Acquisitions in the spine and neurotechnology businesses drove a 12.4 percent net sales increase, while increased unit volume and changes in product mix also contributed to the business line’s success.
The company’s knee and hip business lines also reported a net sales increase of 3.3 percent and 5.1 percent, respectively. During the first quarter, the company incurred $17 million in acquisition- and integration-related charges for Neurovascular, Orthovita, Memometal and Concetric acquisitions.
More articles on Orthopedic Devices:
DePuy Spine Launches Pedicular Screw System for Spinal Fusions
Medtronic Launches Electronic Power Instruments for Spinal Surgery
17 Spine Devices Receive FDA 510(k) Clearance in March
